Description
BoneSigma™ BCP is a bone graft substitute with fully interconnected micro and macropores for complete resorption. It consists of 60% hydroxyapatite (HAp) and 40% beta-tricalcium phosphate (β-TCP) and provides long term stabilization of the surgical site in most dental implant surgeries. BoneSigma™ BCP is available in granule form.
Descriptions
BoneSigma™ BCP is a bone graft substitute with fully interconnected micro and macropores for complete resorption. It consists of 60% hydroxyapatite (HAp) and 40% beta-tricalcium phosphate (β-TCP) and provides long term stabilization of the surgical site in most dental implant surgeries. BoneSigma™ BCP is available in granule form.
Product Specifications
Small Granules
(0.25 – 1.0 mm)
| SKU | Weight |
|---|---|
| BSGB00025 | 0.25 g |
| BSGB0005 | 0.5 g |
| BSGB00075 | 1.0 g |
| BSGB001 | 1.0 g |
Large Granules
(1.0 – 2.0 mm)
| SKU | Weight |
|---|---|
| BSGB1025 | 0.25 g |
| BSGB105 | 0.5 g |
| BSGB1075 | 0.75 g |
NOTE: Multiple package options available.
Indications for Use
BoneSigma™ BCP may be used alone or in combination with autograft to provide a bone void filler that is resorbed/remodeled and is replaced by host bone during the healing process. It is intended for use as a bone graft to fill or reconstruct osseous bone defects or gaps of the skeletal system that are not intrinsic to the stability of the bone structure. These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone.
BoneSigma™ BCP are recommended for:
- Filling of peri-implant defects in conjunction with products intended for guided bone regeneration (GBR)
- Filling of periodontal defects in conjunction with products intended for guided tissue regeneration (GTR) and guided bone regeneration (GBR)
- Reconstruction or augmentation of the alveolar ridge
- Filling of periodontal defects
- Filling of defects after root resection, apicectomy, and cystectomy
- Filling of extraction sockets to enhance preservation of the alveolar ridge
- Elevation of the maxillary sinus floor
Studies
BoneSigma™ BCP is osteoconductive providing a matrix for bone growth. Its biphasic characteristics of HA and TCP allow for a resorption rate similar to that of human bone. Further, it has an interconnected network of macropores and micropores that enables cellular colonization and biological infiltration. BoneSigma™ BCP is validated and documented in clinical studies through universities in the US and abroad and case studies through clinicians involving procedures such as horizontal/vertical augmentation, sinus augmentation, and sinus elevation.
Downloads
Inquiry
This product is only available in selected countries. Please check with a representative for availability and further information. If you are a distributor or clinician and have questions about the product, please submit an inquiry below.